Kamada (NASDAQ:KMDA – Get Rating) posted its earnings results on Tuesday. The biotechnology company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.07), MarketWatch Earnings reports. Kamada had a negative net margin of 6.31% and a negative return on equity of 3.44%. During the same quarter last year, the firm earned $0.06 earnings per share. Kamada updated its FY 2022 guidance to EPS.
NASDAQ KMDA opened at $4.67 on Friday. Kamada has a 1 year low of $4.48 and a 1 year high of $6.96. The company has a fifty day simple moving average of $5.41 and a 200 day simple moving average of $5.90. The company has a quick ratio of 1.16, a current ratio of 2.75 and a debt-to-equity ratio of 0.09.
Several research firms recently issued reports on KMDA. Zacks Investment Research lowered shares of Kamada from a “buy” rating to a “hold” rating in a research note on Friday, May 6th. StockNews.com started coverage on Kamada in a research report on Friday, May 13th. They issued a “buy” rating for the company.
Kamada Company Profile (Get Rating)
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, which are manufactured by third parties.
- Get a free copy of the StockNews.com research report on Kamada (KMDA)
- Rapid7: Could Be Profitable in FY 2022 Despite Bear Market
- Will John Deere’s Earnings Help to Calm the Markets?
- Lowe’s Companies Has Not Bottomed
- Silicon Labs Stock is Falling to a Better Place
- The Institutional Tide Has Turned For Cisco Systems
Receive News & Ratings for Kamada Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kamada and related companies with MarketBeat.com's FREE daily email newsletter.